KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 12 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,794 | -9.2% | 75,000 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $50,438 | -12.7% | 75,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $57,770 | +2.2% | 75,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $56,540 | -5.8% | 75,000 | 0.0% | 0.00% | -20.0% |
| Q3 2022 | $60,000 | -17.8% | 75,000 | -25.0% | 0.01% | -16.7% |
| Q2 2022 | $73,000 | -13.1% | 100,000 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $84,000 | – | 100,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STEELHEAD PARTNERS LLC | 16,000,000 | $16,661,000 | 1.26% |
| Opti Capital Management, LP | 9,000,000 | $9,367,000 | 1.14% |
| Context Capital Management, LLC | 10,500 | $10,883,000 | 1.07% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 20,000,000 | $20,429,000 | 0.20% |
| AQR Arbitrage LLC | 4,100,000 | $4,249,000 | 0.15% |
| FARALLON CAPITAL MANAGEMENT LLC | 25,000,000 | $25,538,000 | 0.13% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 13,500,000 | $13,992,000 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 22,500,000 | $23,319,000 | 0.03% |
| Citadel Advisors | 48,300,000 | $50,405,000 | 0.01% |
| MACKAY SHIELDS LLC | 93,000 | $96,000 | 0.00% |